Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Appointed director
Notes underwriting agrmnt

Avant Diagnostics, Inc (OREO) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2020 SC 13D Avant Diagnostics, Inc reports a 99% stake in ONCBIOMUNE PHARMACEUTICALS, INC.
06/15/2020 3 Avant Diagnostics, Inc (10% Owner) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc
05/13/2019 REVOKED Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
04/09/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
03/26/2019 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series D Preferred Stock, filed with the Nevada Secretary of State on March 15, 2019",
"Form of Subscription Agreement for the Series D Preferred Stock Financing"
03/13/2019 10-Q Quarterly Report for the period ended December 31, 2018
03/01/2019 10-K Annual Report for the period ended September 30, 2018
02/06/2019 8-K Quarterly results
01/30/2019 10-Q Quarterly Report for the period ended June 30, 2018
01/09/2019 10-Q Quarterly Report for the period ended March 31, 2018
12/28/2018 10-Q Quarterly Report for the period ended December 31, 2017
12/04/2018 10-K Annual Report for the period ended September 30, 2017
12/04/2018 10-Q Quarterly Report for the period ended June 30, 2017
10/26/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/23/2018 10-Q Quarterly Report for the period ended March 31, 2017
10/23/2018 10-Q Quarterly Report for the period ended December 31, 2016
10/10/2018 4 Busch Jeffrey (Director) has filed a Form 4 on Avant Diagnostics, Inc
Txns: Granted 50,000 preferred shares @ $1, valued at $50k
09/24/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "AVANT DIAGNOSTICS COMMENTS ON HALT OF TRADING OF COMMON STOCK"
09/21/2018 3 DeLaO Andrew John (Director) has filed a Form 3 on Avant Diagnostics, Inc
09/14/2018 3 SHROTRIYA RAJESH C MD (Director) has filed a Form 3 on Avant Diagnostics, Inc
09/14/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
09/11/2018 4 RUXIN MICHAEL I (CEO) has filed a Form 4 on Avant Diagnostics, Inc
Txns: Granted 25,000 preferred shares @ $1, valued at $25k
08/28/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock, filed with the Nevada Secretary of State on May 25, 2018",
"Form of Subscription Agreement for the Series C Financing"
08/27/2018 10-K Annual Report for the period ended September 30, 2016
07/25/2018 3 Cole Henry (Director) has filed a Form 3 on Avant Diagnostics, Inc
06/14/2018 8-K Appointed a new director
06/12/2018 3 Busch Jeffrey (Director) has filed a Form 3 on Avant Diagnostics, Inc
06/05/2018 3 RUXIN MICHAEL I (CEO) has filed a Form 3 on Avant Diagnostics, Inc
06/04/2018 3 Brugmann John Edward (Director) has filed a Form 3 on Avant Diagnostics, Inc
05/25/2018 8-K Certificate of designation filed, Appointed a new director
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock, filed with the Nevada Secretary of State on May 25, 2018",
"Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock, filed with the Nevada Secretary of State on May 25, 2018",
"Form of Promissory Note issued to 2016 Investors",
"Form of Convertible Promissory Note issued to Coastal Investment Partners, LLC",
"Form of Promissory Note issued to Black Mountain Equity Partners LLC",
"Form of Subscription Agreement for the May 2018 Financing",
"Form of Exchange Agreement by and between the Company and the 2017 Investors and the 2016 Investors",
"Form of Termination Agreement, by and between the Company and the 2017 Investors",
"Exchange Agreement, by and between the Company and Coastal Investment Partners, LLC",
"Termination Agreement, by and between the Company and Coastal Investment Partners, LLC"
04/06/2018 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Asset Purchase Agreement, by and between Avant Diagnostics, Inc. and Amarantus Bioscience Holdings, Inc"
01/03/2018 8-K Other Events
12/18/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Settlement Agreement, by and between Avant Diagnostics, Inc. and Philippe Goix"
11/29/2017 3 TRAPP ROBERT H (Director) has filed a Form 3 on Avant Diagnostics, Inc
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy